array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(638) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(85) "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Corient Private Wealth LLC" ["snippet_en"]=> string(299) "Corient Private Wealth LLC lifted its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 3.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 132,470 shares of the company's stock after purchasing an additional 4,224 shares" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2024-01-24/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-24" ["categories"]=> array(8) { [0]=> string(12) "Stock Market" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(16) "Share Repurchase" [3]=> string(11) "Regulations" [4]=> string(31) "Financial Update/Profit Warning" [5]=> string(14) "Issuing Shares" [6]=> string(18) "General Investment" [7]=> string(24) "Stock Research & Ratings" } } [1]=> array(7) { ["title_en"]=> string(100) "Oregon Public Employees Retirement Fund Sells 5,274 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(300) "Oregon Public Employees Retirement Fund reduced its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 22.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 18,259 shares of the company's stock after selling 5,274 shares during th" ["url"]=> string(76) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-sec-filing-2024-01-10/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-10" ["categories"]=> array(6) { [0]=> string(12) "Stock Market" [1]=> string(16) "Share Repurchase" [2]=> string(11) "Regulations" [3]=> string(14) "Issuing Shares" [4]=> string(18) "General Investment" [5]=> string(10) "Divestment" } } [2]=> array(7) { ["title_en"]=> string(94) "Insider Sell: Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc" ["snippet_en"]=> string(224) "In a notable insider transaction, Executive Vice President James Polewaczyk has parted with 11,636 shares of IDEXX Laboratories Inc (NASDAQ:IDXX), a leader in veterinary diagnostics, software, and water microbiology testing." ["url"]=> string(83) "https://finance.yahoo.com/news/insider-sell-executive-vice-president-060504612.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e3d75832-339c-4bc7-bb5f-f873211b1647" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-12-09" ["categories"]=> array(8) { [0]=> string(12) "Stock Market" [1]=> string(15) "Insider Trading" [2]=> string(20) "Corporate Governance" [3]=> string(14) "Issuing Shares" [4]=> string(12) "Board Change" [5]=> string(10) "Executives" [6]=> string(24) "Stock Research & Ratings" [7]=> string(10) "Divestment" } } [3]=> array(7) { ["title_en"]=> string(66) "IDEXX Laboratories shares with significant price gains (€474.70)" ["snippet_en"]=> string(208) "The shares of IDEXX Laboratories are currently shining on the US stock exchange. The title rose significantly in price on Monday. An increase of 7.01 percent - with this increase in value the security belongs" ["url"]=> string(134) "https://www.finanznachrichten.de/nachrichten-2023-12/60833089-idexx-laboratories-aktie-mit-deutlichen-kursgewinnen-474-70-euro-013.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d8883a32-e80e-45be-9f29-5700ab7e39ed" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2023-12-04" ["categories"]=> array(6) { [0]=> string(12) "Stock Market" [1]=> string(16) "Share Repurchase" [2]=> string(12) "Going Public" [3]=> string(15) "Market Movement" [4]=> string(14) "Issuing Shares" [5]=> string(24) "Stock Research & Ratings" } } [4]=> array(7) { ["title_en"]=> string(77) "IDEXX Laboratories shares hold up well today: share value rises (€398.7669)" ["snippet_en"]=> string(190) "The shares of IDEXX Laboratories are currently trading somewhat more firmly on the US stock exchange. Most recently, investors paid $426.86 for the paper. Shareholders can currently be happy" ["url"]=> string(146) "https://www.finanznachrichten.de/nachrichten-2023-11/60605515-idexx-laboratories-aktie-heute-gut-behauptet-aktienwert-steigt-398-7669-euro-013.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7595e4d2-08b6-45b3-ad5e-99f39afa1c34" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2023-11-08" ["categories"]=> array(9) { [0]=> string(12) "Stock Market" [1]=> string(9) "Investors" [2]=> string(15) "Market Movement" [3]=> string(12) "Going Public" [4]=> string(16) "Share Repurchase" [5]=> string(14) "Issuing Shares" [6]=> string(18) "General Investment" [7]=> string(24) "Stock Research & Ratings" [8]=> string(21) "Shareholders Feedback" } } [5]=> array(7) { ["title_en"]=> string(69) "Stock market: IDEXX Laboratories shares are on the spot (€402.4353)" ["snippet_en"]=> string(190) "The price of IDEXX Laboratories shares is hardly moving. The most recent price was $426.01. Today's trading day has so far brought little price movement for the shares of IDEXX Laboratories." ["url"]=> string(141) "https://www.finanznachrichten.de/nachrichten-2023-10/60452331-aktienmarkt-idexx-laboratories-aktie-tritt-auf-der-stelle-402-4353-euro-013.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/79624c45-447f-4abe-b1b2-097c1d56c1cf" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2023-10-24" ["categories"]=> array(9) { [0]=> string(12) "Stock Market" [1]=> string(15) "Market Movement" [2]=> string(12) "Going Public" [3]=> string(16) "Share Repurchase" [4]=> string(14) "Issuing Shares" [5]=> string(17) "Commodity Pricing" [6]=> string(18) "General Investment" [7]=> string(24) "Stock Research & Ratings" [8]=> string(21) "Competitive Behaviour" } } [6]=> array(7) { ["title_en"]=> string(52) "Idexx Laboratories (IDXX) Shares Cross Below 200 DMA" ["snippet_en"]=> string(276) "In trading on Thursday, shares of Idexx Laboratories, Inc. (Symbol: IDXX) crossed below their 200 day moving average of $478.01, changing hands as low as $476.60 per share. Idexx Laboratories, Inc. shares are currently trading down about 2.2% on the day. The chart below shows" ["url"]=> string(84) "https://www.nasdaq.com/articles/idexx-laboratories-idxx-shares-cross-below-200-dma-0" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-09-07" ["categories"]=> array(2) { [0]=> string(14) "Issuing Shares" [1]=> string(24) "Stock Research & Ratings" } } [7]=> array(7) { ["title_en"]=> string(87) "James F. Polewaczyk Sells 22,909 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock" ["snippet_en"]=> string(249) "IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Free Report) EVP James F. Polewaczyk sold 22,909 shares of the stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $510.56, for a total value of $11,696,419.04." ["url"]=> string(124) "http://www.defenseworld.net/2023/09/02/james-f-polewaczyk-sells-22909-shares-of-idexx-laboratories-inc-nasdaqidxx-stock.html" ["image_url"]=> NULL ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-09-02" ["categories"]=> array(2) { [0]=> string(14) "Issuing Shares" [1]=> string(12) "Stock Market" } } [8]=> array(7) { ["title_en"]=> string(93) "Nordea Investment Management AB Sells 11,208 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)" ["snippet_en"]=> string(246) "Nordea Investment Management AB trimmed its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 47.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC)." ["url"]=> string(131) "http://www.defenseworld.net/2023/05/11/nordea-investment-management-ab-sells-11208-shares-of-idexx-laboratories-inc-nasdaqidxx.html" ["image_url"]=> NULL ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-05-11" ["categories"]=> array(6) { [0]=> string(12) "Stock Market" [1]=> string(11) "Acquisition" [2]=> string(14) "Issuing Shares" [3]=> string(18) "General Investment" [4]=> string(24) "Stock Research & Ratings" [5]=> string(10) "Divestment" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(116) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(65) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(43) } [3]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(43) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(23) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [26]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc